Learn / MAZE
NASDAQ: MAZE
Maze Therapeutics (MAZE) stock, explained like you're 5
Maze Therapeutics trades on the Nasdaq under the ticker MAZE. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
- Ticker
- MAZE
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 1.5 billion dollars
Is Maze Therapeutics a small, medium or large cap company?
No. Maze Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Maze Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MAZE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Technical Reactions to MAZE Trends in Macro Strategies (Stock Traders Daily)
- MAZE Nov 2026 12.500 put (MAZE261120P00012500) interactive stock chart (Yahoo Finance Australia)
- Maze Therapeutics CEO Jason Coloma sells $932,259 in Maze shares (Investing.com)
- 2 People, a 19 Year Old Woman and a 20 Year Old Man, Stabbed After ‘Disagreement’ Escalates Inside Popular 40 Acre Corn Maze (AOL.com)
- MAZE Nov 2026 22.500 call (MAZE261120C00022500) Stock Price, News, Quote & History (Yahoo! Finance Canada)
Follow MAZE in your daily brief
Each trading day at 5 PM ET we post what happened to Maze Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MAZE
Questions about Maze Therapeutics stock
What does Maze Therapeutics do?
Maze Therapeutics trades on the Nasdaq under the ticker MAZE. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
What is the ticker symbol for Maze Therapeutics?
Maze Therapeutics trades under the ticker MAZE on the Nasdaq.
What is Maze Therapeutics's market cap?
Maze Therapeutics is a small cap stock with a market cap of about 1.5 billion dollars.
How does Maze Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MAZE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MAZE stock every day?
Add MAZE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.